Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

De novo induction of genetically engineered brain tumors in mice using plasmid DNA.

Cancer research | Jan 15, 2009

Spontaneous mouse models of cancer show promise to more accurately recapitulate human disease and predict clinical efficacy. Transgenic mice or viral vectors have been required to generate spontaneous models of glioma, a lethal brain tumor, because nonviral gene transfer is typically transient. To overcome this constraint, we used the Sleeping Beauty transposable element to achieve chromosomal integration of human oncogenes into endogenous brain cells of immunocompetent mice. Genetically engineered, spontaneous brain tumors were induced with plasmid DNA in a matter of weeks in three separate mouse strains. The phenotype of tumors was influenced by the combination of oncogenes delivered, resembling human astrocytoma or glioblastoma in the majority of cases. At least five different genes can be cotransfected simultaneously including reporters, allowing measurement of tumor viability by in vivo imaging. This model can accelerate brain tumor research in a variety of ways such as generation of "humanized" models for high throughput drug screening and candidate gene validation with exceptional speed and flexibility.

Pubmed ID: 19147555 RIS Download

Mesh terms: Animals | Brain Neoplasms | DNA | Disease Models, Animal | Female | Genes, Reporter | Genes, Tumor Suppressor | Genetic Engineering | Glioma | Injections, Intraventricular | Male | Mice | Oncogenes | Plasmids | Polyethyleneimine

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, Id: 1R21-NS055738-01A2
  • Agency: NCI NIH HHS, Id: R01 CA160782
  • Agency: NCI NIH HHS, Id: R01CA113636-01A1
  • Agency: NINDS NIH HHS, Id: R21 NS055738
  • Agency: NINDS NIH HHS, Id: R21 NS055738-01A2
  • Agency: NIDA NIH HHS, Id: T32DA022616

Addgene (Reagent, Plasmid)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.